Alkermes
ALKS
#3144
Rank
A$6.66 B
Marketcap
A$40.00
Share price
1.00%
Change (1 day)
-26.38%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): A$0.63 Billion

According to Alkermes's latest financial reports the company's current earnings are A$1.52 Billion. In 2024 the company made an earning of A$0.65 Billion a decrease over its 2023 earnings that were of A$0.80 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.63 B-3.99%
2024 A$0.65 B-17.97%
2023 A$0.80 B-468.52%
2022 -A$0.22 Billion449.24%
2021 -A$39.73 Million-68.04%
2020 -A$0.13 Billion-52.1%
2019 -A$0.26 Billion64.49%
2018 -A$0.16 Billion-15.04%
2017 -A$0.19 Billion-34.2%
2016 -A$0.29 Billion-5.34%
2015 -A$0.3 Billion35084.97%
2014 -A$0.85 Million
2012 A$10.49 M-117.81%
2011 -A$58.96 Million-12.69%
2010 -A$67.52 Million94.3%
2009 -A$34.76 Million-117.7%
2008 A$0.19 B622.63%
2007 A$27.16 M
2004 -A$0.11 Billion-14.48%
2003 -A$0.13 Billion11.88%
2002 -A$0.12 Billion39.65%
2001 -A$80.42 Million5.73%
2000 -A$76.06 Million-28.91%
1999 -A$0.11 Billion237.28%
1998 -A$31.72 Million100.05%
1997 -A$15.86 Million-37.93%
1996 -A$25.55 Million82.72%
1995 -A$13.98 Million-26.79%
1994 -A$19.1 Million-72.78%
1993 -A$70.16 Million208.07%
1992 -A$22.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.81 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.12 B 3,931.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.76 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.87 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$11.36 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$18.51 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-A$0.3 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.39 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.04 B 430.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel